Event JSON
{
"id": "c2342af2ba12b1f3c9474c5fc1d7a513b35b7ec0eddd83bfbf8693c3e6eed168",
"pubkey": "9c41d1165a76eda7abb3db9d665e67fdd23320dd1a8c6a65ff40a65935d667cc",
"created_at": 1734731012,
"kind": 1,
"tags": [
[
"r",
"https://www.cnbc.com/2024/12/20/fda-approves-eli-lillys-weight-loss-drug-zepbound-for-sleep-apnea.html"
],
[
"subject",
"FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S."
],
[
"published_at",
"1734730833"
],
[
"image",
"https://image.cnbcfm.com/api/v1/image/108001062-1719945039163-gettyimages-2126120470-ZEPBOUND_PATIENT_SHORTAGES.jpeg?v=1734214590\u0026w=1920\u0026h=1080"
],
[
"p",
"9c41d1165a76eda7abb3db9d665e67fdd23320dd1a8c6a65ff40a65935d667cc",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://image.cnbcfm.com/api/v1/image/108001062-1719945039163-gettyimages-2126120470-ZEPBOUND_PATIENT_SHORTAGES.jpeg?v=1734214590\u0026w=1920\u0026h=1080"
],
[
"t",
"mainstream:perspective"
],
[
"summary",
"The FDA has approved Eli Lilly's Zepbound injection pen for treating patients with moderate-to-severe obstructive sleep apnea, a condition that affects an estimated 20 million people in the US. The drug, which was previously approved for obesity treatment, is now cleared for use in patients with obesity and moderate-to-severe OSA. The approval is expected to pave the way for broader insurance coverage for Zepbound, which is not currently covered by many insurance plans. The drug has been shown to be effective in reducing the severity of OSA in clinical trials, with almost half of patients achieving 'disease resolution' after taking the highest dose."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqn3qaz9j6wmk602anmwwkvhn8lhfrxgxar2xx5e0lgzn9jdwkvlxqy56fv4\nhttps://image.cnbcfm.com/api/v1/image/108001062-1719945039163-gettyimages-2126120470-ZEPBOUND_PATIENT_SHORTAGES.jpeg?v=1734214590\u0026w=1920\u0026h=1080\nThe agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.\nhttps://www.cnbc.com/2024/12/20/fda-approves-eli-lillys-weight-loss-drug-zepbound-for-sleep-apnea.html",
"sig": "28f549b5846091f01bf65df80ce571f5a0489377a88cdc942162ab921cffcf428a4c79992906d7745729982529df8e36f100544d6828e888c5d2d01af4a1c2f7"
}
